跳至主要内容
临床试验/CTRI/2019/05/019293
CTRI/2019/05/019293招募中未知

ââ?¬Å?Magnesium sulfate ( MAGSALF) for fetal neuroprotection given in spontaneous preterm birth versus magnesium sulfate for hypertensive disorder of pregnancy versus preterm newborn not receiving magsalf ââ?¬â?? A comparative prospective cohort study

King Georges Medical University0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Women with established preterm labour (regular uterine contraction with cervical dilatation of ââ?°Â¥4 cm )at gestational age of less than 32 weeks.
  • 2. Women requiring iatrogenic preterm labour / cesarean at gestatonal age less than 32 weeks
  • 3. Women with severe pre-Eclampsia or Eclampsia having preterm labour being given magnesium sulphate at less than 32 weeks .

排除标准

  • 1.Myasthenia gravis
  • 2.Acute renal failure
  • 3.False preterm
  • 4.Gestational age more than 32 weeks

研究者

发起方
King Georges Medical University

相似试验